1. Edelman, William C, Kiianitsa, Kostantin, Virmani, Tuhin, Raskind, Wendy H, Korvatska, Olena. 2022. Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutations. In Parkinsonism & related disorders, 101, 31-38. doi:10.1016/j.parkreldis.2022.06.015. https://pubmed.ncbi.nlm.nih.gov/35779466/
2. Bernardo, Pia, Cuccurullo, Claudia, Rubino, Marica, Bilo, Leonilda, Coppola, Antonietta. 2024. X-Linked Epilepsies: A Narrative Review. In International journal of molecular sciences, 25, . doi:10.3390/ijms25074110. https://pubmed.ncbi.nlm.nih.gov/38612920/
3. Taguchi, Tomomi, Kimura, Kaori, Suzuki, Agena, Sasaki, Shugo, Miyatsuka, Takeshi. 2023. ATP6AP2 is robustly expressed in pancreatic β cells and neuroendocrine tumors, and plays a role in maintaining cellular viability. In Scientific reports, 13, 9260. doi:10.1038/s41598-023-36265-3. https://pubmed.ncbi.nlm.nih.gov/37286698/
4. Zhao, Kankan, Wang, Mengchuan, Wu, Aiguo. 2020. ATP6AP2 is Overexpressed in Breast Cancer and Promotes Breast Cancer Progression. In Cancer management and research, 12, 10449-10459. doi:10.2147/CMAR.S270024. https://pubmed.ncbi.nlm.nih.gov/33122944/
5. Dubos, Aline, Castells-Nobau, Anna, Meziane, Hamid, Schenck, Annette, Herault, Yann. 2015. Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration. In Human molecular genetics, 24, 6736-55. doi:10.1093/hmg/ddv380. https://pubmed.ncbi.nlm.nih.gov/26376863/
6. Wendling, Olivia, Champy, Marie-France, Jaubert, Solène, Reilly, Patrick T, Hérault, Yann. 2017. Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies. In Scientific reports, 7, 9618. doi:10.1038/s41598-017-08845-7. https://pubmed.ncbi.nlm.nih.gov/28851918/